Indication

Myxedema coma

Myxedema coma is a rare, life-threatening endocrine emergency representing the decompensated extreme of severe, longstanding hypothyroidism. Read more about Myxedema coma

19 drugs 17 manufacturers

Advertisement

Drugs that treat it

Common Myxedema coma therapies.

Showing 1–9 of 19 drugs

Filter & compare in the drug finder →Opens the drug finder with Myxedema coma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Myxedema coma.

Myxedema coma is a rare, life-threatening endocrine emergency representing the decompensated extreme of severe, longstanding hypothyroidism.

It primarily affects older adults, particularly elderly women, and involves widespread multiorgan system failure triggered when homeostatic adaptations collapse, often precipitated by systemic infection, cold exposure, trauma, surgery, or central nervous system depressants.

Pathophysiologically driven by profound cellular thyroid hormone deficiency, it is clinically defined by altered sensorium—ranging from lethargy and confusion to stupor or frank coma—alongside severe hypothermia, bradycardia, hypoventilation with hypercapnia, hypotension, and generalized mucopolysaccharide tissue infiltration leading to classic nonpitting myxedematous edema.

Personalize your experience

Follow Myxedema coma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it